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Objectives. The purpose of this study was to determine the
prognostic value of automatic quantitative analysis in exercise dual-
isotope myocardial perfusion single-photon emission computed to-
mography (SPECT) and to compare the prognostic value of quanti-
tative analysis to semiquantitative visual SPECT analysis.
Background. Extent, severity and reversibility of exercise myo-
cardial perfusion defects have been shown to correlate with progno-
sis. However, most studies examining the prognostic value of SPECT
in chronic coronary artery disease (CAD) have been based on visual
analysis by experts.
Methods. We studied 1,043 consecutive patients with known or
suspected CAD who underwent rest Tl-201/exercise Tc-99m sesta-
mibi dual-isotope myocardial perfusion SPECT and were followed
up for at least 1 year (mean 20.0 6 3.7 months). After censoring
59 patients with early coronary artery bypass grafting or percu-
taneous transluminal coronary angioplasty, <60 days after nu-
clear testing, the final population consisted of 984 patients (36%
women, mean age 63 6 12 years).
Results. During the follow-up period, 28 hard events (14
cardiac deaths, 14 nonfatal myocardial infarctions) occurred.
Patients with higher defect extent (>10%), severity (>150) and
reversibility (>5%) by quantitative SPECT defect analysis, as well
as those with an abnormal scan (>2 abnormal segments, summed
stress score >4 and summed difference score >2) by semiquan-
titative visual SPECT analysis, had a significantly higher hard
event rate compared to patients with a normal scan (p < 0.001).
With both visual and quantitative analyses, hard event rates of
approximately 1% with normal scans and 5% with abnormal scans
(p > 0.05) were observed over the 20-month follow-up period. A
Cox proportional hazards regression model showed that chi-
square increased similarly with the addition of quantitative defect
extent and visual summed stress score variables after considering
both clinical and exercise variables (improvement chi-square 5 11
for both, p < 0.0007). There were no significant differences in the
areas under receiver operating characteristic curves between
quantitative and visual analysis (p > 0.70). Linear regression
analysis also indicated that quantitative assessments correlated
well with visual semiquantitative assessments.
Conclusions. The findings of this study indicate that automatic
quantitative analysis of exercise stress myocardial perfusion
SPECT is similar to semiquantitative expert visual analysis for
prognostic stratification. These findings may be of particular
clinical importance in laboratories with less experienced visual
interpreters.
(J Am Coll Cardiol 1998;32:1987–95)
©1998 by the American College of Cardiology
Visual analysis of extent, severity and reversibility of defects in
exercise myocardial perfusion single-photon emission com-
puted tomography (SPECT) has been shown to provide clini-
cally important incremental prognostic information in patients
with known coronary or suspected artery disease (CAD) (1–3).
Despite the literature establishing the prognostic value of
SPECT, significant variability may be observed in interpreta-
tion by less experienced readers. Use of an automatic quanti-
tative analysis program would minimize variability across hos-
pitals or readers and elevate the consistency of image
interpretation independent of reader skill. We have previously
developed a quantitative analysis program (Cedars-Emory
quantitative analysis software) (CEqual) for assessment of
rest/stress Tc-99m sestamibi SPECT (4,5), and have validated
this approach for the detection of coronary artery disease in a
multicenter trial (5). Separate normal limits for assessment of
rest Tl-201/stress Tc-99m sestamibi dual-isotope SPECT have
been developed, and have preliminarily been shown to have
high reproducibility (6). The prognostic value, however, of this
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quantitative analysis has not yet been examined. The purpose
of this study was to determine the prognostic value of auto-
matic quantitative analysis in patients undergoing exercise
dual-isotope myocardial perfusion SPECT and to compare the
prognostic value of quantitative analysis with that of semiquan-
titative visual SPECT analysis.
Methods
Study population. The study population consisted of 1,043
consecutive patients with known or suspected CAD who
underwent rest Tl-201/exercise Tc-99m sestamibi dual-isotope
myocardial perfusion SPECT between January 1, 1993 and
October 31, 1994 at Cedars-Sinai Medical Center. All patients
were followed up for at least 1 year after testing. Patients with
known nonischemic cardiomyopathy or valvular heart disease
were excluded. Of the initial population, 32 patients with early
coronary artery bypass grafting and 27 patients with early
percutaneous transluminal coronary angioplasty, within 60
days after nuclear testing, were censored from analysis since
their referral to revascularization was, in large part, due to
their scan results (7,8). After censoring, the final population
included 984 patients (36% women, mean age 63 6 12 years).
Exercise myocardial perfusion protocol. All patients un-
derwent rest Tl-201/exercise Tc-99m sestamibi separate acqui-
sition dual-isotope myocardial perfusion SPECT, as previously
described (9). Briefly, Tl-201 (3.0 to 4.0 mCi) was injected
intravenously at rest, with dose variation based on patient
weight. Rest Tl-201 SPECT was begun 10 min after radioiso-
tope injection. Immediately after imaging, patients performed
a symptom-limited exercise treadmill test (ETT) using the
standard Bruce protocol with 12-lead electrocardiographic
(ECG) recording each minute of exercise and continuous
monitoring of leads aVF, V1 and V5. Blood pressure was
measured and recorded at rest, at the end of each exercise
stage and at peak exercise. Exercise end points included
physical exhaustion, severe angina, sustained ventricular tachy-
cardia, hemodynamically significant supraventricular dysrhyth-
mias or significant exertional hypotension. The maximal de-
gree of ST segment change at 80 ms after the J point of the
ECG was measured and assessed as horizontal, upsloping or
downsloping. Exercise ECG responses were considered unin-
terpretable if the patients were taking digoxin or had a paced
ventricular rhythm or if the baseline ECG demonstrated left
ventricular hypertrophy, nonspecific ST-T wave changes, left
or right bundle branch block or Wolff–Parkinson–White syn-
drome. At near-maximal exercise, Tc-99m sestamibi (25 to
35 mCi) was injected intravenously, with dose variation based
on patient weight. Exercise was continued at maximal work-
load for 1 min and at one stage lower for two additional
minutes, when possible. Technetium-99m sestamibi SPECT
imaging was begun 15 to 30 min after radiopharmaceutical
injection.
SPECT acquisition protocol. All SPECT acquisitions were
as previously described (9) employing a large field of view
gamma camera and a low energy high resolution collimator to
obtain 64 projections at 20 s/projection over a semicircular
180° arc extending from the 45° right anterior oblique to the
45° left anterior oblique projection. For Tl-201 SPECT, two
energy windows were utilized, a 30% window centered on the
68- to 80-keV peak and a 20% window centered on the
167-keV peak. For Tc-99m sestamibi SPECT, a 15% window
centered on the 140-keV peak was used. Images were acquired
using a 64 3 64 image matrix. All images were subject to
quality control measures, including cinematic display for as-
sessment of patient motion, corrections for field nonuniformity
and center of rotation. No attenuation or scatter correction
was used. Patients with resting defects were often asked to
return the next day for a 24-h delayed Tl-201 imaging to assess
reversibility (10). Whenever available, these late redistribution
thallium images were used in place of the resting ones for both
visual and quantitative interpretation.
Automatic reconstruction and quantification of myocardial
perfusion SPECT. Dual-isotope SPECT tomograms were re-
constructed and reoriented using an automatic algorithm
described by Germano et al. (11). When automatic reconstruc-
tion or reorientation failed, reconstruction limits and axes were
assigned manually. The remainder of the automatic quantita-
tive process was performed by modifying the CEqual algorithm
originally described by Ezekiel et al. (12) and Garcia et al. (13)
with the addition of an automatic segmentation algorithm
described by Germano et al. (11). The left ventricle (LV) is
described by an apex and base location, with a center coordi-
nate and average radius. Myocardial sampling consists of
generation of maximum count circumferential profiles using a
spherical search for the apex and a cylindrical search for the
remainder of the short-axis tomograms. The pixel locations
corresponding to the maximal myocardial counts, as well as the
count values, are determined. The LV radius is reset to the
average radius in the circumferential profile, and the basal slice
for assessment is determined by the slice with a maximum
count of 50% or less than the hottest myocardial slice. The
final sampling of the myocardium is made using these values.
Modifications to the previously described CEqual algorithm
were as follows. The identification of the LV is based on a
clustering algorithm applied to short-axis reconstructed tomo-
grams. By applying adaptive thresholding to iteratively define
clusters corresponding to expected ventricular volumes, the
Abbreviations and Acronyms
CAD 5 coronary artery disease
CEqual 5 Cedars-Emory quantitative analysis software
ECG 5 electrocardiographic
ETT 5 exercise treadmill test
LV 5 left ventricle
ROC 5 receiver operating characteristic
SDS 5 summed difference score
SPECT 5 single-photon emission computed tomography
SRS 5 summed rest score
SSS 5 summed stress score
TID 5 transient ischemic dilation
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algorithm separates myocardium from potential extracardiac
structures reflecting hepatic, splenic or gut activity. If the
results of the clustering approach fail to meet certain criteria,
the algorithm applies a Hough transform and a scoring func-
tion weighted to favor a doughnut-like configuration (11).
Prior to comparison to normal limits the stress and rest profiles
are normalized to the most normal wall of the patient’s entire
stress data set (4). Separate normal limits were generated and
used for the myocardial perfusion evaluation of stress Tc-99m
sestamibi and rest Tl-201 (14). A quality control report is
generated to allow operator verification of the performance of
the automatic algorithm and to manually correct any subopti-
mal values. The count values are plotted on a two-dimensional
polar map representing the entire LV myocardium. The crite-
ria for abnormality used for this evaluation were determined by
receiver operating characteristic (ROC) curve analysis of the
number of standard deviations from the mean which best
separated visually normal from abnormal dual-isotope myocar-
dial perfusion on a region by region basis (4). These optimal
standard deviations were used as thresholds of abnormality for
the total myocardium and three major myocardial regions (left
anterior descending artery, left circumflex coronary artery and
right coronary artery). Quantitative defect extent was defined
by summation of the number of profile points falling below the
dual-isotope normal limit expressed as percentage of the LV
myocardium. Quantitative defect “severity” (actually a mea-
sure of defect extent and severity) was defined by the sum of
the product of all profile points below the normal limits
multiplied by their respective number of standard deviations
below the normal mean count (15). Quantitative defect revers-
ibility was calculated by scaling the rest and stress images to a
common value of the most normal region of the stress distri-
bution and subtracting the stress from the rest data (Fig. 1).
Defect extent .10% of LV, defect severity index .150 and
defect reversibility .5% of LV were defined as abnormal (16).
When automatic LV identification or quantitation steps failed,
the studies were subjected to observer-guided quantitative
analysis using the standard commercially available algorithm
(17).
Semiquantitative visual analysis of myocardial perfusion
SPECT. Semiquantitative visual interpretation of SPECT per-
fusion images used short-axis and vertical long-axis tomograms
divided into 20 segments for each patient (9,18). These seg-
ments were assigned to six evenly spaced regions in apical,
midventricular and basal slices of the short-axis views and two
apical segments on the midventricular vertical long-axis slice.
Each segment was scored by consensus of two expert observers
using a five-point scoring system (0 5 normal; 1 5 equivocal;
2 5 moderate; 3 5 severe reduction of radioisotope uptake;
4 5 absence of detectable radiotracer in a segment). Apparent
perfusion defects, which were considered to be caused by soft
tissue attenuation, were assigned a score of 1. The observers
were unaware of the patient’s clinical history and results of
stress ECG testing.
Three global perfusion indices previously defined by our
group were employed to combine assessments of defect extent
and severity (3). A summed stress score (SSS) was obtained by
adding the scores of the 20 segments of the stress sestamibi
images. A summed rest score (SRS) was similarly obtained by
adding the scores of the 20 segments of the rest Tl-201 images
or 24-h delayed Tl-201 images. The sum of the differences
between the stress and rest scores of each of the 20 segments
was defined as the summed difference score (SDS) or revers-
ibility score, an index of jeopardized myocardium. Summed
difference score .2 was considered a reversible defect abnor-
mality. A segment was considered abnormal if the segmental
score was $2. Segments with scores of 1 on both stress and rest
images were considered to reflect attenuation and were con-
sidered as scores of 0-0 for purpose of analysis (1). Images
were also visually assessed for the presence of transient
ischemic dilation (TID) of the LV (19).
Likelihood of coronary artery disease. For the purpose of
examining patients in different risk subsets, we used analyses of
the pre- and post-ETT likelihood of CAD as aggregate clinical
descriptors of proven prognostic importance. The pre-ETT
likelihood was calculated using CADENZA (20) and was
based on Bayesian analysis of age, gender, symptom classifica-
tion, rest ECG, cardiac risk factors and the results of ECG
stress testing. The post-ETT likelihood was based on pre-ETT
likelihood of CAD, and the clinical and ECG responses to
stress (3). Neither of these variables considered the informa-
tion from the nuclear test.
Patient follow-up. Follow-up was performed by dedicated
research personnel. The follow-up duration was at least 1 year,
mean 20.0 6 3.7 months. Hard events were defined as either
cardiac death (confirmed by review of death certificate and
hospital chart of physician’s records) or nonfatal myocardial
infarction (documented by appropriate ECG and cardiac
enzyme level changes). If a patient was found to have had both
events after nuclear testing, only cardiac death was considered.
Figure 1. Defect extent represents the number of pixels that fall below
the normal (Nl) limit (% abnormal), defect severity represents the
degree of abnormality within the defined defect zone, measured by the
area between the patient’s profile and the normal limit profile, and
defect reversibility represents the number of pixels that fall above the
normal limit (% reversibility).
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Statistical analysis. All continuous variables are expressed
as means 6 SD. The mean differences for continuous variables
were compared using the Student t test (two tailed). All
analyses comparing the frequency of cardiac events based on
the perfusion defect size, severity and reversibility were per-
formed using a chi-square statistic. Linear regression analysis
was used to determine the correlation for perfusion defect
between variables of visual and quantitative SPECT. A p value
,0.05 was considered statistically significant in all analyses.
Receiver operating characteristic curve analysis repre-
sented sensitivities and false positive rates for predicting
cardiac events for quantitative versus visual SPECT. The
difference between the area under two ROC curves was
calculated and compared (21). Receiver operating character-
istic areas were expressed as the area 6 SE.
The Cox proportional hazards regression model (22) was
used to assess the incremental prognostic value of components
of testing. A stepwise multivariate Cox regression analysis
(SPSS version 7.5) was performed by using the following: 1) a
composite clinical variable alone (pre-ETT likelihood of CAD/
ischemia) (model 1); 2) a composite of clinical 1 exercise
variables (post-ETT likelihood of CAD/ischemia) (model 2);
3) clinical 1 exercise 1 the best nuclear variable (quantitative
defect extent or visual SSS). The increment in prognostic value
by nuclear testing was determined after “forcing in” the most
predictive prescan variables and then adding the most predic-
tive nuclear variables (model 3). The chi-square value was
calculated from the log of the ratio of maximal partial likeli-
hood functions.
Results
Patient characteristics and outcome events. The clinical
characteristics of the 984 uncensored patients in this study are
shown in Table 1. During the follow-up period, 28 hard events,
including 14 cardiac deaths and 14 nonfatal myocardial infarc-
tions occurred. Patients with hard events had more frequent
prior myocardial infarction and hypertension and higher post-
ETT likelihood of CAD than patients without hard events (p ,
0.05).
Automatic processing success rate. The success rate was
787/984 (80%) for the automatic LV reconstruction portion of
the program and 911/984 (93%) for the automatic CEqual
program.
Comparison between quantitative and semiquantitative
visual analyses of defect extent, severity and reversibility.
Table 2 compares the various related quantitative and semi-
quantitative visual assessments in all patients by gender. Close
correlations were noted for all assessments: quantitative defect
extent versus number of abnormal segments (r 5 0.68) and
versus SSS (r 5 0.70), quantitative defect severity versus SSS
(r 5 20.75) and quantitative defect reversibility versus SDS
(r 5 0.67). Comparison of quantitative and semiquantitative
visual assessments by gender revealed significantly closer cor-
relation in men than women (p , 0.001).
Table 1. Clinical Characteristics of Patients With and Without
Hard Events
Total
(n 5 984)
Events
(n 5 28)
No Events
(n 5 956) p
Age (yr) 63 6 12 65 6 15 63 6 12 NS
Gender (female) 352 (36%) 8 (28%) 344 (36%) NS
Prior MI 206 (21%) 11 (39%) 195 (20%) 0.027
Prior PTCA 126 (13%) 3 (11%) 123 (13%) NS
Prior CABG 128 (13%) 6 (21%) 122 (13%) NS
Hypertension 412 (42%) 18 (64%) 394 (41%) 0.025
Diabetes 118 (12%) 6 (21%) 112 (12%) NS
Hypercholesterolemia 429 (44%) 13 (46%) 416 (44%) NS
Smoking 139 (14%) 7 (25%) 132 (14%) NS
Anginal symptoms 410 (42%) 17 (61%) 393 (41%) NS
Pre-ETT Lk CAD 0.46 6 0.31 0.43 6 0.20 0.38 6 0.25 NS
Ischemic ECG 221 (22%) 10 (36%) 211 (22%) NS
Post-ETT Lk CAD 0.33 6 0.34 0.56 6 0.38 0.33 6 0.34 0.004
CABG 5 coronary artery bypass surgery; ECG 5 electrocardiogram; ETT 5
exercise treadmill test; Lk CAD 5 likelihood of coronary artery disease; MI 5
myocardial infarction; PTCA 5 percutaneous transluminal coronary angioplasty.
Table 2. Correlations Between Quantitative and Visual Assessments in Total Patients (n 5 1043),
Men (n 5 678) and Women (n 5 365)
Gender Coefficient Intercept SEE r Value p Value
Defect extent vs. # of abnl segments Total 0.169 20.036 0.108 0.68 0.0001
Male 0.187 20.103 0.150 0.70* 0.0001
Female 0.119 0.099 0.134 0.62 0.0001
Defect extent vs. SSS Total 0.446 20.144 0.272 0.70 0.0001
Male 0.501 20.476 0.375 0.73* 0.0001
Female 0.302 0.430 0.342 0.61 0.0001
Defect severity vs. SSS Total 20.012 1.595 0.214 20.75 0.0001
Male 20.012 2.026 0.292 20.76* 0.0001
Female 20.010 1.070 0.286 20.68 0.0001
Defect reversibility vs. SDS Total 0.441 1.003 0.189 0.67 0.0001
Male 0.470 1.169 0.262 0.68* 0.0001
Female 0.322 0.860 0.236 0.58 0.0001
*p , 0.001 men vs. women. abnl 5 abnormal; SDS 5 summed difference score; SEE 5 standard error of estimates;
SSS 5 summed stress score.
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Nuclear variables and outcome events. Nuclear variables
of the study patients with and without hard events by quanti-
tative defect analysis and semiquantitative visual analysis are
illustrated in Table 3. Quantitative defect analysis showed that
patients with events had significantly higher defect extent,
severity and reversibility compared to patients without events
(p , 0.005). Semiquantitative visual analysis also showed that
patients with events had more perfusion defects, and greater
defect extent and severity (SSS) and reversibility (SDS) (p ,
0.007). However, there was no significant difference in TID in
the patients with and without events.
Frequency of event as a function of scan results. Hard
event rates as a function of quantitative defect extent versus
the number of abnormal segments detected visually over the
20-month follow-up period are shown in Figure 2. The event
rate rose significantly as a function of defect extent by both
quantitative and visual analysis (p , 0.001). The hard event
rate as a function of defect severity by quantitative versus
visual methods is shown in Figure 3. By either method of
defining defect severity, patients had low event rates in the
setting of a normal scan, intermediate event rates with a mildly
abnormal scan and high event rates with a moderately to
severely abnormal scan (p , 0.001). The hard event rate of
defect reversibility by quantitative versus visual methods is
shown in Figure 4. With both methods, patients with less defect
reversibility had similarly low hard event rates, and patients
with more defect reversibility had similar relatively high hard
event rates (p , 0.001). There was no significant difference in
the distribution of events in each group with matched quanti-
tative and semiquantitative visual scan results (p . 0.05) in
Figures 2, 3, and 4. However, a significantly higher proportion
of the population was categorized as normal by the semiquan-
titative visual method than by quantitative analysis (p , 0.05).
Multivariate analysis and incremental value. The stepwise
multivariate cox proportional hazards model demonstrated
that the post-ETT likelihood of CAD was an independent
clinical predictor of hard events (chi-square 5 11, p , 0.005),
although clinical variables were not predictive. Table 4 showed
that chi-square increased significantly and to the same degree
with the addition of quantitative defect extent and visual SSS
variables after assessment by the clinical 1 exercise model
(improvement in chi-square 5 11 for both, p , 0.0007). The
visual nuclear variables screened for entry into the model
included SSS, SDS, TID and a multivessel disease pattern of
CAD. After adjusting for SSS, the other variables were no
longer significant (p . 0.10). With respect to quantitative
variables, the entry of defect extent into a model resulted in
nonsignificance of the remaining variables.
Comparison of prognostic value between quantitative and
visual analysis. The areas under ROC curves were identically
high for predicting hard events between corresponding quan-
titative and visual analyses. There were no significant differ-
ences between defect extent and number of abnormal seg-
ments (0.72 vs. 0.74, p 5 0.74, Fig. 5), defect severity and SSS
Figure 4. Hard event rates over the 20-month follow-up period in
patients with exercise sestamibi single-photon emission computed
tomography by quantitative analysis (solid bars) and semiquantitative
visual analysis (open bars) as a function of defect reversibility. *p ,
0.001. Quant 5 quantitative; Rev 5 reversibility; SDS 5 summed
difference score.
Table 3. Nuclear Variables of Patients With and Without
Hard Events
Events
(n 5 28)
No Events
(n 5 956) p
Quantitative analysis
Defect extent 22.8 6 13.5 12.7 6 12.9 0.0006
Defect severity 602 6 456 325 6 500 0.0037
Defect reversibility 11.7 6 8.9 6.3 6 9.1 0.0038
Visual analysis
Abnormal segments 4.6 6 3.3 2.0 6 3.1 0.0002
SSS 11.7 6 7.4 5.2 6 8.0 0.0006
SDS 7.1 6 6.5 3.4 6 5.7 0.0063
TID 2 (7.1%) 34 (3.6%) 0.6460
SDS 5 summed difference score; SSS 5 summed stress score; TID 5
transient ischemic dilation of the left ventricle.
Figure 2. Hard event rates over the 20-month follow-up period in
patients with exercise sestamibi single-photon emission computed
tomography by quantitative analysis (solid bars) and semiquantitative
visual analysis (open bars) as a function of stress defect extent. *p ,
0.001. Abnl 5 abnormal; Ext 5 extent; Quant 5 quantitative; Seg 5
segment.
Figure 3. Hard event rates over the 20-month follow-up period in
patients with exercise sestamibi single-photon emission computed
tomography by quantitative analysis (solid bars) and semiquantitative
visual analysis (open bars) as a function of stress defect severity. *p ,
0.001. Q 5 quantitative; Sev 5 severity; SSS 5 summed stress score.
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(0.73 vs. 0.75, p 5 0.86, Fig. 6) or defect reversibility and SDS
(0.70 vs. 0.70, p 5 0.98, Fig. 7).
Discussion
Exercise myocardial perfusion SPECT with Tc-99m sesta-
mibi is routinely used for a wide variety of clinical applications
in assessing patients with suspected or known CAD (23). By
semiquantitative visual analysis, a number of previous studies
have evaluated the prognostic value of exercise myocardial
perfusion scintigraphy with this radiopharmaceutical technique
(1,3,24,25). Inherent in this semiquantitative visual analysis is
the dependence on the subjective interpretation of the ob-
server. Most of the studies reporting the prognostic effective-
ness of myocardial perfusion scintigraphy have been based on
the visual assessments of experienced expert readers. Less
experienced observers may have difficulty reproducing the
expert-derived results. An objective, quantitative analysis
would circumvent this dependence on visual analysis and
would increase the consistency of expert interpretation and
minimize variability for all readers. Given the need to develop
evidence-based medicine, this automatic quantitative analysis
would foster the assimilation of prognostic evidence from large
populations into daily clinical decision making.
In the present study, the various objective quantitative
indices performed equally well compared to analogous consen-
sus expert visual analyses for assessment of prognosis. With
both visual and quantitative analyses, hard event rates of
approximately 1% with normal scans and 5% with abnormal
scans (p . 0.05) were observed over the 20-month follow-up
period. Multivariate analysis demonstrated the same incre-
mental prognostic value for quantitative defect extent and
visual SSS after clinical and exercise variables were considered.
By ROC curve areas, in comparison to semiquantitative visual
Table 4. Multivariable Cox Proportional Hazards Models
Model Coefficient Odds Ratio
Improvement
Chi-Square p Value
Clinical 20.9986 0.3684 0.1775 0.2970
Clinical 1 exercise 1.8542 6.3863 10.9834 0.0021
Clinical 1 exercise
1 defect extent
0.0415 1.0424 10.8084 0.0007
Clinical 21.3603 0.2566 0.1775 0.1771
Clinical 1 exercise 1.8895 6.6164 10.9834 0.0016
Clinical 1 exercise
1 SSS
0.0651 1.0672 10.8210 0.0005
SSS 5 summed stress score.
Figure 5. Receiver operating characteristic curves performed for
quantitative (Quant) defect extent (area 5 0.72 6 0.04) and the
number of abnormal segments (area 5 0.74 6 0.05). There is no
significant difference in prognostic accuracy (p 5 0.74).
Figure 6. Receiver operating characteristic curves performed for
quantitative (Quant) defect severity (area 5 0.73 6 0.04) and the
summed stress score (area 5 0.75 6 0.04). There is no significant
difference in prognostic accuracy (p 5 0.86). SSS 5 summed stress
score.
Figure 7. Receiver operating characteristic curves performed for
quantitative defect reversibility (area 5 0.70 6 0.05) and the summed
difference score (SDS) (area 5 0.70 6 0.05). There is no significant
difference in prognostic accuracy (p 5 0.98).
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analysis, automatic quantitative analysis of corresponding scin-
tigraphic variables performed equally well for prognostic as-
sessment. Linear regression analysis also indicated close rela-
tionships between quantitative and semiquantitative visual
assessments for defect extent, severity and reversibility vari-
ables. Since a single reader interprets images in most clinical
settings, the fact that quantitative analysis was nearly equiva-
lent to consensus visual analysis takes on greater clinical
importance. It should be noted, however, that with the current
quantitative method, a significantly greater proportion of
patients were categorized as low risk by semiquantitative visual
analysis than by quantitative analysis (Figs. 2 and 3, p , 0.001).
Most likely this is related to the lack of incorporation of
artificial intelligence rules for the recognition of artifacts with
the current quantitative software. Evidence supporting this
explanation is seen in the stronger correlations of quantitative
analysis with expert visual analyses in men than women.
Although we used gender-matched normal limits for quantita-
tion, the program does not account for differences between
women in breast size and breast attenuation, thus creating a
problem in recognition of marked breast attenuation as an
artifact. With expert visual analysis, on the other hand, this
pattern is frequently identifiable. Even though automatic
quantitation is intrinsically more reproducible, this particular
quantitative implementation can still benefit from expert as-
sessment of artifacts in the segment of the population most
affected by them.
Quantitative Tl-201 or Tc-99m sestamibi myocardial perfu-
sion SPECT has been shown to be accurate for detection and
localization of CAD (26,27), and assessment of myocardial
infarct size (28,29), and correlates highly with expert visual
interpretation (5). Previous validations of CEqual were based
on determination of the diagnostic accuracy of the program
(5,17). These validations were conducted using both expert
visual analysis and coronary angiography as the “gold stan-
dard.” In preliminary reports, the results for CEqual with the
dual-isotope imaging protocol have been shown to be similar
for detection of the presence or absence of CAD (14). These
results would be expected, since the same stress myocardial
perfusion agent and dose were used for both protocols. Only
limited data are available, however, regarding the prognostic
value of quantitative myocardial perfusion SPECT. Miller et
al. (30) and Mahmarian et al. (26) have documented the
prognostic value of quantitative myocardial perfusion SPECT
assessment in patients with acute myocardial infarction. Kamal
et al. (31) and Pancholy et al. (32) have reported the prognostic
value of adenosine quantitative thallium SPECT and exercise
quantitative thallium SPECT in women. Both studies found
that patients with large perfusion defect ($15% of myocar-
dium) had worse outcome than patients with no or small
perfusion defect (,15% of myocardium). To our knowledge
this is the first study to employ quantitative Tc-99m sestamibi
SPECT analysis in assessment of prognosis in a large popula-
tion of patients with chronic CAD and to systematically
compare the results of semiquantitative visual and quantitative
assessment for prognosis.
A large number of studies have documented the impor-
tance of stress myocardial perfusion SPECT with sestamibi in
risk stratification (1,3,19,33,34) and in guiding patient manage-
ment (3,35,36). All of these reports have relied on the expert
semiquantitative visual analysis of myocardial perfusion
SPECT studies. In previous studies from our laboratory,
objective quantitative analysis was not employed for prognostic
assessment, since it was not a routine part of our daily quality
controlled data acquisition. The reliance on semiquantitative
visual inspection by experts has limited the degree to which the
results from our individual center can be generalized to other
laboratories. The present study was made feasible by the
advent of an automatic approach to identification of the LV for
quantitative assessment of myocardial perfusion SPECT, since
this new step allowed automatic batch processing of the
scintigraphic data. The results of the present study, in which an
objective quantitative analysis is found to contain prognostic
information indistinguishable from that of the expert semi-
quantitative analysis, suggests that these prognostic results
could be obtained in any laboratory providing high quality
exercise imaging protocols, acquisition, processing and quan-
titation. This result has potential major implications for the
field of nuclear cardiology and represents a clinically important
advantage over stress echocardiography, which at the current
time has no widely utilized objective quantitative analysis.
The main improvement noted between the previous CEqual
program and this version was in the success rate observed for
the automatic processing function. Improved methods for
identifying the myocardium, and selection of apex, base, center
and radius resulted in a processing success rate of 93%
(911/984). The success rate for the previous CEqual version
was clinically noted to be around 70% to 75%. This improve-
ment in the automatic processing component of the algorithm
resulted in an increase in the objectivity and likely the repro-
ducibility of the CEqual quantitative analysis program.
In this study, a number of other variables that have been
shown to be significant markers of severe and extensive CAD
or harbingers of adverse outcomes, such as a multivessel
disease pattern, were shown not to be significant predictors in
a multivariable analysis after adjusting for the extent and
severity of perfusion abnormalities. We have previously shown
that the presence of TID, multivessel perfusion abnormalities
and perfusion abnormalities in a left anterior descending
artery distribution (3,37), after adjusting for the extent and
severity of stress perfusion abnormalities in a multivariable
model, are no longer predictive of adverse outcomes. For all of
these variables, the greater associated risk is based in large part
on the tendency of these patterns to be present in patients with
severe and extensive perfusion abnormalities.
Study limitations. Although the present study was per-
formed in a relatively large group of patients, the results are
based on a population referred for nuclear testing, and thus
potentially different from unbiased CAD populations. Not
many hard events occurred in this study group, in which 61%
(605 patients) had normal scans by visual analysis, limiting the
ability to perform subanalyses such as the difference in prog-
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nostic importance of fixed or reversible defects or male versus
female findings. Visually assessed TID was not of prognostic
importance in this study. The potential incremental prognostic
value of quantitative TID could not be assessed in this report,
since the gated SPECT program required for the automatic
analysis of TID was not being utilized at the time of the study.
Conclusions. The results of this study demonstrate that
automatic quantitative analysis of exercise dual-isotope myo-
cardial perfusion SPECT has comparable prognostic value to
that of semiquantitative visual analysis. The findings suggest
that the type of prognostic information reported using semi-
quantitative visual analysis by experts may be achieved by a
more widely applicable, objective quantitative analysis, which
may be of particular clinical importance in laboratories with
less experienced visual interpreters.
We gratefully acknowledge the technical assistance of Theresa Tripodi and
Romalisa Miranda.
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